CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-19). The draft was written by AI, the existence of all 4 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 595 · Search date 2026-07-19 · Methodology v0.6

Probiotics-fermented garlic extract,
does it really help with Improved liver enzymes and support for liver health?

30-Second Summary
C
Evidence Grade C · 40 · Safety caution
Fermented garlic extract has limited liver-enzyme signals but has not been shown to improve fatty liver or clinical liver disease
What the
research shows
Probiotics-fermented garlic extract is rated C because a 12-week randomized double-blind placebo-controlled trial in 75 adults with mildly elevated GGT found time-course differences in ALT and GGT. At week 12, however, the between-group ALT comparison was significant while GGT was borderline at P=0.066, and liver enzymes are surrogates rather than symptoms, steatosis, fibrosis, or liver-disease events. No independent replication of the same ingredient was found, and evidence is concentrated in individually recognized ingredient No. 2016-16. This is a different fermented formulation and liver-enzyme claim from the ordinary-garlic blood-pressure and cholesterol axis in verdict 076.
What the
ads claim
Marketing can expand an ALT or GGT laboratory signal into removal of fatty liver, detoxification, or recovery from liver disease. Direct evidence concerns one specific fermented garlic extract for 12 weeks in adults with mildly elevated GGT; improvement in diagnosed fatty liver, hepatitis, fibrosis, or clinical outcomes has not been established.
*

Useful facts when choosing a product

  • Probiotics-fermented garlic extract No. 2016-16 is an individually recognized functional ingredient with a specific manufacturing process and specification. It cannot be assumed equivalent to fresh garlic, black garlic, or ordinary garlic powder.
  • The recognized wording is that it may help support liver health, not a drug indication for treating liver disease. Products can contain additional ingredients, so the actual amount and daily serving of fermented garlic extract should be checked.
  • The single 12-week trial found no difference in adverse-event prevalence, but long-term safety is not well established. Garlic products can cause gastrointestinal discomfort, allergy, and possibly increased bleeding tendency.
  • People taking anticoagulants or antiplatelet medicines, those awaiting surgery, and anyone with elevated liver enzymes should consult a clinician. Unexplained abnormal liver tests should not be self-treated with a supplement.
Gap Measurement · Verdict 595 · C 40
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Kim and colleagues gave probiotics-fermented garlic extract or placebo for 12 weeks to 75 adults with mildly elevated GGT. The primary week-12 between-group GGT comparison was null at p=.066, while group-by-time signals were p=.022 for GGT and p=.014 for ALT. Imaging-defined steatosis, fibrosis, and clinical outcomes were not assessed. Recognition No. 2016-16 is not independent replication, and ordinary garlic or black-garlic studies used different formulations and were not pooled.

02

Why this is classified as C (40)

The primary GGT comparison was null at p=.066 in a single 75-person, 12-week trial; only group-by-time enzyme signals remained. Enzymes are surrogates, imaging, fibrosis, and clinical outcomes were absent, and evidence is concentrated in one recognized ingredient. Rules ① and ②-b therefore place the verdict at C with 40 points. Ordinary garlic and black garlic are separate evidence bases.

Counterpoint. After cause evaluation and lifestyle management, a person with mildly elevated enzymes might consider the ingredient as an adjunct within the product label. Evaluation and standard care for alcohol exposure, obesity or diabetes, viral hepatitis, and drug-induced injury take priority.

Rejudgment record. New verdict — Accepted ALT and GGT signals from a 75-person 12-week randomized trial but applied the C ceiling under rules ①, ②-b, and ④ because the primary week-12 GGT comparison was P=0.066, outcomes were surrogate enzymes, evidence came from one recognized ingredient, and independent replication was absent

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improvement in the ALT and GGT liver-enzyme surrogatesCA single 75-person trial found time-course signals, but the week-12 between-group comparison for primary GGT was P=0.066.
Improvement in clinical liver disease, including steatosis, hepatitis, or fibrosis?No human trial of the same ingredient assessing imaging, fibrosis, or clinical outcomes was found.
Treatment of liver disease because the ingredient is individually recognizedFRecognition as a functional-food ingredient is not approval as a treatment for liver disease.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Kim HN et al. 2017Randomized double-blind placebo-controlled trial39Functional-ingredient development context; limited conflict reporting in the article recordPrimary change in serum GGT; ALT and adverse eventsGroup-by-time signals were p=.022 for GGT and p=.014 for ALT, but the primary week-12 between-group GGT comparison was null at p=.066.Only direct human efficacy trial
Korean individual recognition No. 2016-16Korean regulatory individual-recognition record1Ingredient dossier submitted by SK BiolandFunctional wording that the ingredient may support liver healthProbiotics-fermented garlic extract was recognized as No. 2016-16.Confirms study existence and product identity; not evidence-grade support
Sangouni AA et al. 2020 ordinary garlic powder trialRandomized double-blind placebo-controlled trial in nonalcoholic fatty liver disease110Iranian academic researchUltrasound steatosis, liver enzymes, and lipidsSome steatosis and enzyme improvement was reported with ordinary garlic powder, but it is not the No. 2016-16 fermented ingredient.Indirect formulation evidence; not treated as direct replication
§

Receipt — 4 References

All 4 cited sources were verified for existence at the original page (as of 2026-07-19).

Kim HN, Kang SG, Roh YK, Choi MK, Song SW. Efficacy and safety of fermented garlic extract on hepatic function in adults with elevated serum gamma-glutamyl transpeptidase levels: A double-blind, randomized, placebo-controlled trial. Eur J Nutr. 2017;56(5):1993-2002. PMID: 27743130. DOI: 10.1007/s00394-016-1318-6.
checked
Ministry of Food and Drug Safety. 2016 Third Health Functional Food Review Committee results: recognition of probiotics-fermented garlic extract; individual recognition No. 2016-16. 2016. PMID: none. DOI: none.
checked
Sangouni AA, Azar MRMH, Alizadeh M. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial. Br J Nutr. 2020;124(4):450-456. PMID: 32312333. DOI: 10.1017/S0007114520001403.
checked
Kawasaki Y, Yagi-Tamura K, Goto J, Shimizu K, Ohnuki K. Effect of Fermented Black Garlic on Hepatic Function in Japanese Adults: A Placebo-controlled, Double-blinded, Randomized Trial. J Jpn Soc Nutr Food Sci. 2017;70(3):109-115. PMID: none. DOI: 10.4327/jsnfs.70.109.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-19 · Corrections: none

Cite this verdict

Probiotics-fermented garlic extract x improved liver enzymes and liver health Evidence Grade C card
[Chamgap] Probiotics-fermented garlic extract x improved liver enzymes and liver health — Evidence Grade C·40. 4 cited sources checked. Source: https://chamgap.com/en/verdicts/liver/probiotics-fermented-garlic-extract-liver-enzymes/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.